11732405

Source:http://linkedlifedata.com/resource/pubmed/id/11732405

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019196, umls-concept:C0087111, umls-concept:C0907160, umls-concept:C1442989
pubmed:issue	44
pubmed:dateCreated	2001-12-4
pubmed:language	ger
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100893959
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1438-3276
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	143
pubmed:owner	NLM
pubmed:pagination	58
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:11732405-Antiviral Agents, pubmed-meshheading:11732405-Clinical Trials as Topic, pubmed-meshheading:11732405-Drug Therapy, Combination, pubmed-meshheading:11732405-Hepatitis C, pubmed-meshheading:11732405-Humans, pubmed-meshheading:11732405-Interferon-alpha, pubmed-meshheading:11732405-Multicenter Studies as Topic, pubmed-meshheading:11732405-Recombinant Proteins, pubmed-meshheading:11732405-Ribavirin, pubmed-meshheading:11732405-Time Factors
pubmed:year	2001
pubmed:articleTitle	[PEG-interferon alfa 2a against hepatitis C. Better as the standard therapy].
pubmed:publicationType	Journal Article, Comparative Study